The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis treatment Xeljanz. It is ...
HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...
Scientists say research into a vaccine for HIV is further along than it’s ever been. But Trump administration cuts to scientific research have set that effort back. Including a promising trial for an ...
Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...
A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...
Chronic Hepatitis D virus (HDV) infection represents the most severe form of viral hepatitis. Inhibition of viral replication is a promising strategy to achieve HDV cure but is challenging due to our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results